Alpha-1 antitrypsin is a potential biomarker for hepatitis B

Virology Journal

Volumn 8, Issue , 2011, Pages

  Tan, Xu Fei ^a,b   Wu, Shan Shan ^a   Li, Shu Ping ^a   Chen, Zhi ^a   Chen, Feng ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; SERPINA1 PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; LIVER CARCINOMA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE ANALYSIS; PEPTIDE MASS FINGERPRINTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TWO DIMENSIONAL ELECTROPHORESIS; BLOOD; CHEMISTRY; MASS SPECTROMETRY; MICROARRAY ANALYSIS; SERUM; TWO DIMENSIONAL GEL ELECTROPHORESIS;

HEPATITIS B VIRUS;

ALPHA 1-ANTITRYPSIN; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPATITIS B; HUMANS; MASS SPECTROMETRY; MICROARRAY ANALYSIS; SERUM;

EID: 79957811075     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-274     Document Type: Article

References (23)

1. Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. HL Sharp RA Bridges W Krivit EF Freier, J Lab Clin Med 1969 73 934 9 4182334
2. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. S Eriksson J Carlson R Velez, N Engl J Med 1986 314 736 9 10.1056/NEJM198603203141202 3485248 (Pubitemid 16124387)
3. Hepatitis B virus immunopathogenesis. FV Chisari C Ferrari, Annu Rev Immunol 1995 13 29 60 10.1146/annurev.iy.13.040195.000333 7612225
4. Proteomics: Taking over where genomics leaves off. S Borman, Chem Eng News 2000 78 31 31 37 10.1021/cen-v078n031.p031
5. Personal commentary on proteomics. DF Hunt, J Proteome Res 2002 1 15 9 12643521
6. A proteomic approach for the discovery of early detection markers of hepatocellular carcinoma. LF Steel TS Mattu A Mehta H Hebestreit R Dwek AA Evans WT London T Block, Dis Markers 2001 17 179 89 11790885 (Pubitemid 34014697)
7. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma. QY He R Zhu T Lei MY Ng JM Luk P Sham GK Lau JF Chiu, J Cell Biochem 2008 103 740 52 10.1002/jcb.21443 17557278 (Pubitemid 351240611)
8. Tissue microarray technology for high-throughput molecular profiling of cancer. OP Kallioniemi U Wagner J Kononen G Sauter, Hum Mol Genet 2001 10 657 62 10.1093/hmg/10.7.657 11257096 (Pubitemid 32331572)
9. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. XW Xu MH Lu DM Tan, Clin Microbiol Infect 2005 11 52 6 10.1111/j.1469-0691.2004.01029.x 15649304
10. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. M Wilm A Shevchenko T Houthaeve S Breit L Schweigerer T Fotsis M Mann, Nature 1996 379 466 9 10.1038/379466a0 8559255
11. A comparative study of polyclonal and monoclonal antibodies for immunocytochemical localization of cytosolic aspartate aminotransferase in rat liver. CT Lin LH Chen TS Chan, J Histochem Cytochem 1983 31 920 6 10.1177/31.7.6854005 6854005 (Pubitemid 13043579)
12. Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3. H Pan F Hong S Radaeva B Gao, Cell Mol Immunol 2004 1 43 9 16212920
13. Proteomic detection of changes in protein expression induced by cordycepin in human hepatocellular carcinoma BEL-7402 cells. P Shi Z Huang X Tan G Chen, Methods Find Exp Clin Pharmacol 2008 30 347 53 10.1358/mf.2008.30.5. 1186085 18806893
14. Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. Y Feng ZM Tian MX Wan ZB Zheng, World J Gastroenterol 2007 13 2608 14 17552011 (Pubitemid 46938833)
15. Proteomic analysis of ubiquitinated proteins in normal hepatocyte cell line Chang liver cells. F Tan L Lu Y Cai J Wang Y Xie L Wang Y Gong BE Xu J Wu Y Luo B Qiang J Yuan X Sun X Peng, Proteomics 2008 8 2885 96 10.1002/pmic. 200700887 18655026
16. Proteomics in biomarker discovery and drug development. QY He JF Chiu, J Cell Biochem 2003 89 868 86 10.1002/jcb.10576 12874822
17. Comparative proteomic analysis of de-N-glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status. MA Comunale TS Mattu MA Lowman AA Evans WT London OJ Semmes M Ward R Drake PR Romano LF Steel TM Block A Mehta, Proteomics 2004 4 826 38 10.1002/pmic.200300625 14997503 (Pubitemid 38339160)
18. Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study. TC Poon AY Hui HL Chan IL Ang SM Chow N Wong JJ Sung, Clin Chem 2005 51 328 35 10.1373/clinchem.2004.041764 15590748 (Pubitemid 40175802)
19. Tissue microarrays for high-throughput molecular profiling of tumor specimens. J Kononen L Bubendorf A Kallioniemi M Barlund P Schraml S Leighton J Torhorst MJ Mihatsch G Sauter OP Kallioniemi, Nat Med 1998 4 844 7 10.1038/nm0798-844 9662379 (Pubitemid 28331029)
20. Tissue microarray: a new technology for amplification of tissue resources. DL Rimm RL Camp LA Charette J Costa DA Olsen M Reiss, Cancer J 2001 7 24 31 11269645
21. Detection of novel gene expression in paraffin-embedded tissues by isotopic in situ hybridization in tissue microarrays. GD Frantz TQ Pham FV Peale Jr KJ Hillan, J Pathol 2001 195 87 96 10.1002/1096-9896(200109)195:1<87:: AID-PATH932>3.0.CO;2-4 11568895
22. The human plasma proteome: history, character, and diagnostic prospects. NL Anderson NG Anderson, Mol Cell Proteomics 2002 1 845 67 10.1074/mcp.R200007- MCP200 12488461
23. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis. J Yu AY Hui ES Chu AS Cheng MY Go HL Chan WK Leung KF Cheung AK Ching YL Chui KK Chan JJ Sung, Gut 56 991 9